This report provides an analysis of Executive Order 16-09, which addresses the opioid use public health crisis in Washington. It examines the legal, ethical, and policy implications of the order, particularly focusing on its impact on opioid prescribing practices and the treatment of chronic pain. The report discusses the challenges faced by doctors, the potential for restricting access to necessary medications, and the ethical dilemmas that may arise. It also considers the policy's alignment with patient safety and quality improvement acts, its role in raising awareness, and its potential for regulating illegal drug supply. The analysis further explores the ethical considerations through the lenses of Deontology and Utilitarianism, weighing the pros and cons of the action-based approach adopted by the order. It concludes by recommending a balanced approach that combines supply control with ensuring access for legitimate medical purposes, advocating for a focus on both actions and desired outcomes.